Involvement of HSP90 in ischemic postconditioning-induced cardioprotection by inhibition of the complement system, JNK and inflammation

Acta Cir Bras. 2020 Mar 20;35(1):e202000105. doi: 10.1590/s0102-865020200010000005. eCollection 2020.

Abstract

Purpose: To investigate whether heat shock protein 90 (HSP90) is involved in complement regulation in ischemic postconditioning (IPC).

Methods: The left coronary artery of rats underwent 30 min of occlusion, followed by 120 min of reperfusion and treatment with IPC via 3 cycles of 30s reperfusion and 30s occlusion. The rats were injected intraperitoneally with 1 mg/kg HSP90 inhibitor geldanamycin (GA) after anesthesia. Eighty rats were randomly divided into four groups: sham, ischemia-reperfusion (I/R), IPC and IPC + GA. Myocardial infarct size, apoptosis index and the expression of HSP90, C3, C5a, tumor necrosis factor (TNF)-alpha, interleukin (IL)-1β and c-Jun N-terminal kinase (JNK) were assessed.

Results: Compared with the I/R injury, the IPC treatment significantly reduced infarct size, release of troponin T, creatine kinase-MB, and lactate dehydrogenase, and cardiomyocyte apoptosis. These beneficial effects were accompanied by a decrease in TNF-α, IL-1β, C3, C5a and JNK expression levels. However, all these effects were abrogated by administration of the HSP90 inhibitor GA.

Conclusion: HSP90 exerts a profound effect on IPC cardioprotection, and may be linked to the inhibition of the complement system and JNK, ultimately attenuating I/R-induced myocardial injury and apoptosis.

MeSH terms

  • Animals
  • Benzoquinones / pharmacology*
  • Complement System Proteins / metabolism*
  • Creatine Kinase, MB Form / metabolism
  • HSP90 Heat-Shock Proteins / antagonists & inhibitors*
  • Inflammation Mediators
  • Ischemic Postconditioning / methods
  • JNK Mitogen-Activated Protein Kinases / metabolism*
  • Lactams, Macrocyclic / pharmacology*
  • Male
  • Myocardial Infarction / metabolism*
  • Myocardial Reperfusion Injury / metabolism*
  • RNA, Messenger / metabolism
  • Random Allocation
  • Rats
  • Rats, Sprague-Dawley
  • Tumor Necrosis Factor-alpha / metabolism

Substances

  • Benzoquinones
  • HSP90 Heat-Shock Proteins
  • Inflammation Mediators
  • Lactams, Macrocyclic
  • RNA, Messenger
  • Tumor Necrosis Factor-alpha
  • Complement System Proteins
  • JNK Mitogen-Activated Protein Kinases
  • Creatine Kinase, MB Form
  • geldanamycin